ALPS Group Inc Ordinary Share (NASDAQ:ALPS – Get Free Report) saw a significant decrease in short interest in the month of July. As of July 31st, there was short interest totaling 16,382 shares, a decrease of 47.3% from the July 15th total of 31,101 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average daily trading volume, of 53,359 shares, the days-to-cover ratio is currently 0.3 days.
Analysts Set New Price Targets
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of ALPS Group Inc Ordinary Share in a research report on Monday, July 6th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company has an average rating of “Sell”.
Check Out Our Latest Report on ALPS Group Inc Ordinary Share
ALPS Group Inc Ordinary Share Trading Up 0.1%
About ALPS Group Inc Ordinary Share
ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.
Further Reading
- Five stocks we like better than ALPS Group Inc Ordinary Share
- Uncle Sam’s Chip Trick: How the Government Built a Silicon Moat
- 3 Infrastructure Stocks Built Around the Backbone of the Economy
- Moonshot to Money: Intuitive Machines Lands $600M Defense Win
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
Receive News & Ratings for ALPS Group Inc Ordinary Share Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALPS Group Inc Ordinary Share and related companies with MarketBeat.com's FREE daily email newsletter.
